Skip to content

Study · Non-randomized trial · 1990

4 results

[Effectiveness of immunostimulants in nonspecific ulcerative colitis].

Perederiĭ VG, Tkach SM, Bychkova NG, Blazhenko IL

Sovetskaia meditsina1 Jan 1990

PMID2374965 (opens in a new tab)PepBankPUB-02374965
Publisher pageAsk about this study
Jump to 4 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study4

1 result from studies that gave the peptide. 1 result from people.

  1. 01HumanNon-randomized trialEfficacy outcome

    In nonspecific ulcerative colitis, thymalin and sodium nucleinate showed the highest clinical and immunologic efficacy among the immunostimulants studied, particularly when used together.

    In plain wordsIn ulcerative colitis, thymalin and sodium nucleinate worked best among the immune treatments tested, especially when used together.

    Peptide
    Thymalin
    Outcome
    IncreaseClinical and immunologic efficacy
    Study

    n: not reported in source

    Comparator
    Other tested immunostimulants
    Outcome group
    Immune response · Immune and inflammation
    Studied dose
    Dose not stated

    Source sentences

    Summary
    Thymalin and sodium nucleinate showed the highest clinical and immunologic efficacies, particularly if used together.
    1 context sentence
    Summary · context
    Clinical and immunologic efficacies of some immunostimulants (levamisole, sodium nucleinate, thymic preparations) included in therapeutic schemes in nonspecific ulcerous colitis both separately and in various combinations were under study.

Studies that did not test the peptide alone3

In this study, Thymalin was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Thymalin.

  1. 02HumanNot a test of Thymalin aloneNon-randomized trialEfficacy outcome

    In ulcerative colitis, pooled immunostimulant efficacy depended on severity and was highest with mild disease.

    In plain wordsIn ulcerative colitis, pooled immunostimulant treatment worked best in mild disease.

    Peptide
    Thymalin
    Outcome
    IncreaseEfficacy by disease severity
    Study

    n: not reported in source

    Comparator
    More severe disease
    Outcome group
    Gastrointestinal protection · Gastrointestinal

    Source sentences

    Summary
    The efficacy of these stimulants was found to depend on the disease severity and proved to be the highest in the light course.
    1 context sentence
    Summary · context
    Clinical and immunologic efficacies of some immunostimulants (levamisole, sodium nucleinate, thymic preparations) included in therapeutic schemes in nonspecific ulcerous colitis both separately and in various combinations were under study.

    In this study, Thymalin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymalin.

  2. 03HumanNot a test of Thymalin aloneNon-randomized trialEfficacy outcome

    In ulcerative colitis, the thymalin and sodium nucleinate combination showed particularly high clinical efficacy among the tested immunostimulant regimens.

    In plain wordsIn ulcerative colitis, thymalin with sodium nucleinate showed particularly high clinical efficacy among the tested immune treatments.

    Peptide
    Thymalin
    Outcome
    IncreaseClinical efficacy
    Study

    n: not reported in source

    Outcome group
    Gastrointestinal protection · Gastrointestinal

    Source sentences

    Summary
    Thymalin and sodium nucleinate showed the highest clinical and immunologic efficacies, particularly if used together.
    1 context sentence
    Summary · context
    Clinical and immunologic efficacies of some immunostimulants (levamisole, sodium nucleinate, thymic preparations) included in therapeutic schemes in nonspecific ulcerous colitis both separately and in various combinations were under study.

    In this study, Thymalin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymalin.

  3. 04HumanNot a test of Thymalin aloneNon-randomized trialEfficacy outcome

    In ulcerative colitis, the thymalin and sodium nucleinate combination showed particularly high immunologic efficacy among the tested immunostimulant regimens.

    In plain wordsIn ulcerative colitis, thymalin with sodium nucleinate showed particularly high immune efficacy among the tested immune treatments.

    Peptide
    Thymalin
    Outcome
    IncreaseImmunologic efficacy
    Study

    n: not reported in source

    Outcome group
    Immune response · Immune and inflammation

    Source sentences

    Summary
    Thymalin and sodium nucleinate showed the highest clinical and immunologic efficacies, particularly if used together.
    1 context sentence
    Summary · context
    Clinical and immunologic efficacies of some immunostimulants (levamisole, sodium nucleinate, thymic preparations) included in therapeutic schemes in nonspecific ulcerous colitis both separately and in various combinations were under study.

    In this study, Thymalin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymalin.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    14 Oct 2026, 05:02 UTC

    Study results updated

  2. Version 1

    14 Oct 2026, 01:46 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.